Sue, S.; Suzuki, Y.; Sasaki, T.; Kaneko, H.; Irie, K.; Komatsu, K.; Maeda, S.
Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori. J. Clin. Med. 2023, 12, 5443.
https://doi.org/10.3390/jcm12175443
AMA Style
Sue S, Suzuki Y, Sasaki T, Kaneko H, Irie K, Komatsu K, Maeda S.
Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori. Journal of Clinical Medicine. 2023; 12(17):5443.
https://doi.org/10.3390/jcm12175443
Chicago/Turabian Style
Sue, Soichiro, Yuichi Suzuki, Tomohiko Sasaki, Hiroaki Kaneko, Kuniyasu Irie, Kazuto Komatsu, and Shin Maeda.
2023. "Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori" Journal of Clinical Medicine 12, no. 17: 5443.
https://doi.org/10.3390/jcm12175443
APA Style
Sue, S., Suzuki, Y., Sasaki, T., Kaneko, H., Irie, K., Komatsu, K., & Maeda, S.
(2023). Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori. Journal of Clinical Medicine, 12(17), 5443.
https://doi.org/10.3390/jcm12175443
